CLC genomics WB premium software and reagents for tripler army medical center, hawaii

Active Purchase Order Awarded Last action

Contract number
W81K0223P0109
Awardee
Awarding agency
Obligated
$112,442

Award facts

Opportunity
Contract value 74% obligated
$151,708.04 Current and potential, with all options
Completion date 78% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Germantown, MD, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00012 -$34,071
Other Administrative Action P00011 · Genomics premium software and reagents $0
Other Administrative Action P00010 $0
Funding Only Action P00009 $37,377
Supplemental Agreement for work within scope P00008 · Qiagen CLC genomics WB premium software and reagents -$51,790
Exercise an Option P00007 · CLC genomics WB premium software and reagents, exercise option 3: 01 OCT 2025 - 30 SEP 2026 $0
Supplemental Agreement for work within scope P00006 · Qiagen software and reagents (TAMC), FY25 funds available and acws transition, tripler army medical center, HI $87,382
Supplemental Agreement for work within scope P00005 · CLC genomics WB premium software and reagents(TAMC), deobligation of FY24 funds -$4,673
Supplemental Agreement for work within scope P00004 · CLC genomics WB software and reagents (TAMC), deobligation of FY24 funds. -$59,877
Exercise an Option P00003 · CLC genomics WB software and reagents (TAMC), exercise option II, 01 october 2024 - 30 september 2025 $0
Funding Only Action P00002 · Qiagen software and reagents (TAMC), FY24 funds availability for option 1: 01 OCT 2023 - 30 SEP 2024 $90,367
Exercise an Option P00001 $0
Original award $47,727
Show all 13

About this award

The Defense Health Agency awarded a purchase order to Qiagen, LLC for CLC Genomics WB Premium Software and Reagents to support Tripler Army Medical Center, Hawaii, with a ceiling value of $151,708.04 and an award date of September 1, 2023. Performance extends through September 30, 2027. Work is performed in Germantown, Maryland. The requirement covers genomics premium software and reagents to support extraction protocols for genomic DNA, bacterial DNA, viral nucleic acid, and total RNA analysis. The order originated from a May 2023 pre-solicitation notice issued by the Medical Readiness Contracting Office—Pacific under FAR Part 12 procedures.

Quick answers

Who was awarded contract W81K0223P0109?

W81K0223P0109 was awarded to Qiagen, LLC by Defense Health Agency (Department of Defense) on September 1, 2023.

How much is contract W81K0223P0109 worth?

The government has obligated $112,442 on W81K0223P0109. Its current value, with exercised options, is $151,708.

Was contract W81K0223P0109 competed?

The extent of competition for W81K0223P0109 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award